Evidence map›Paper›PMID 20146080›Full record

ArticleCellular and molecular life sciences : CMLS2010

P2X7, NMDA and BDNF receptors converge on GSK3 phosphorylation and cooperate to promote survival in cerebellar granule neurons.

Felipe Ortega, Raquel Pérez-Sen, Verónica Morente, Esmerilda G Delicado, Maria Teresa Miras-Portugal

Open access · hybridAbstract read
In one paragraph

Article in Cellular and molecular life sciences : CMLS, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 2 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 2 syntheses or guidelines pooled it, 70 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Review
  4. Antifibrotic effect of the P2X7 receptor antagonist A740003 against acute myocardial infarction-induced fibrotic remodelling.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. BDNF as a Promising Therapeutic Agent in Parkinson's Disease.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Review
  15. Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells.International journal of molecular sciences · 2019
    Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Felipe OrtegaDepartment of Biochemistry, Veterinary Faculty, Complutense University of Madrid, Madrid, Spain.
Raquel Pérez-Sen
Verónica Morente
Esmerilda G Delicado
Maria Teresa Miras-Portugal
Universidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycogen synthase kinase-3 (GSK3) is a key player in the regulation of neuronal survival. Herein, we report evidence of an interaction between P2X7 receptors with NMDA and BDNF receptors at the level of GSK3 signalling and neuroprotection. The activation of these receptors in granule neurons led to a sustained pattern of GSK3 phosphorylation that was mainly PKC-dependent. BDNF was the most potent at inducing GSK3 phosphorylation, which was also dependent on PI3K. The P2X7 agonist, BzATP, exhibited additive effects with both NMDA and BDNF to rescue granule neurons from cell death induced by PI3K inhibition. This survival effect was mediated by the PKC-dependent GSK3 pathway. In addition, ERK1/2 proteins were also involved in BDNF protective effect. These results show the function of ATP in amplifying neuroprotective actions of glutamate and neurotrophins, and support the role of GSK3 as an important convergence point for these survival promoting factors in granule neurons.

Indexed as

Adenosine TriphosphateAnimalsBrain-Derived Neurotrophic FactorCell SurvivalCerebellumChromonesCytoplasmic GranulesGlycogen Synthase Kinase 3Mitogen-Activated Protein KinasesModels, BiologicalMorpholinesNeuronsN-MethylaspartatePhosphoinositide-3 Kinase InhibitorsPhosphorylationProtein Kinase C2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one3'-O-(4-benzoyl)benzoyladenosine 5'-triphosphateAdenosine TriphosphateBrain-Derived Neurotrophic FactorChromonesGlycogen Synthase Kinase 3Mitogen-Activated Protein KinasesMorpholinesN-MethylaspartatePhosphoinositide-3 Kinase InhibitorsProtein Kinase CProtein Kinase InhibitorsReceptors, N-Methyl-D-AspartateReceptors, Purinergic P2Receptors, Purinergic P2X7Receptor, trkB

Identifiers

PMID20146080
PMCPMC2858808
OpenAlexW2012185326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.